TalkMed (SGX:5G3) appointed KPMG Corporate Finance as independent financial adviser for the proposed privatization of the company by way of a scheme of arrangement, according to a filing with the Singapore Exchange on Thursday.
In an earlier filing, TW Troy offered to acquire all the issued and paid-up shares in the company's capital by way of a scheme of arrangement.
TW Troy would pay or procure a payment of SG$0.456 in cash per scheme share held by shareholders.
Shares of the company gained over 1% in recent trade.
Price (SGD): S$0.45, Change: S$+0.0050, Percent Change: +1.12%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。